
Doctor Martin Unverdorben
Daiichi Sankyo, Inc., Basking Ridge, NJ (United States of America)
Follow
Contributor content
Presentation
One-year effectiveness and safety outcomes of edoxaban treatment in Chinese patients with atrial fibrillation: First snapshot of more than 4,800 patients from the ETNA-AF-China study
Presentation

